Organigram Global Executive and Leadership Team

Gregory Engel, the Chief Executive Officer at Organigram Global, directs the overarching corporate strategy and global expansion initiatives. Engel oversees the development and execution of business plans aimed at increasing Organigram's market presence in Canada and establishing new international partnerships. This leadership role involves guiding the company's mission to produce high-quality, indoor-grown cannabis for both patient and recreational markets. By focusing on operational excellence and strategic growth, Gregory Engel ensures the company remains at the forefront of the cannabis industry. The Chief Executive Officer's purview extends to fostering innovation across all departments, driving the company's financial performance, and maintaining strong relationships with stakeholders and regulatory bodies. Engel's strategic direction is critical for navigating the evolving legal landscape and maximizing Organigram's global footprint.

Gregory Guyatt, the Chief Financial Officer at Organigram Global, manages all financial operations and strategic financial planning. Guyatt oversees budgeting, forecasting, and capital allocation to support Organigram's production of high-quality cannabis and its expansion into international markets. This role is crucial for ensuring the financial health and sustainability of the corporation, including its portfolio of adult-use recreational cannabis brands. By implementing robust financial controls and driving fiscal discipline, Gregory Guyatt supports the company's growth objectives and enhances shareholder value. The Chief Financial Officer's responsibilities include managing investor relations, securing necessary funding for operational scaling, and optimizing financial performance across all business units. Guyatt's financial acumen is vital for navigating the complexities of the cannabis industry and achieving Organigram's long-term strategic goals.

Timothy Emberg, the President (Canada) at Organigram Global, directs all operational activities and strategic initiatives within the Canadian market. Emberg is responsible for overseeing the production and distribution of Organigram's high-quality, indoor-grown cannabis for patients and adult recreational consumers across Canada. This leadership role is pivotal in managing the company's portfolio of legal adult-use recreational cannabis brands, including The Edison Cannabis Company, Ankr Organics, and Trailblazer. By ensuring operational efficiency and market responsiveness, Timothy Emberg drives Organigram's success in its primary domestic market. The President (Canada)'s focus includes optimizing cultivation processes, managing supply chain logistics, and fostering strong relationships with Canadian distributors and retailers. Emberg's leadership is essential for expanding Organigram's footprint and solidifying its position as a leading cannabis producer in Canada.

Helen Martin, the Chief Legal Officer at Organigram Global, oversees all legal affairs and ensures compliance with regulatory frameworks governing cannabis production and distribution. Martin manages the legal aspects of Organigram's domestic operations in Canada and its international business partnerships, safeguarding the corporation's interests. This position is critical for navigating the complex legal landscape of the cannabis industry, including intellectual property, corporate governance, and contract law. By providing expert legal counsel, Helen Martin supports the company's mission to deliver high-quality cannabis products while mitigating legal risks. The Chief Legal Officer's duties encompass advising on corporate strategy, managing litigation, and ensuring adherence to all applicable laws and regulations. Martin's legal expertise is fundamental to Organigram's sustained growth and market integrity.